Caraco Recalls Digoxin Over Irregular Dosage Fears

Law360, New York (March 31, 2009, 12:00 AM EDT) -- Generics maker Caraco Pharmaceutical Laboratories Ltd. has recalled several batches of heart medication Digoxin amid fears that some pills may contain abnormal dosages of the drug's eponymous active ingredient.

The U.S. Food and Drug Administration announced the voluntary recall Tuesday, warning customers who purchased certain Digoxin products to return those products to their pharmacy or place of purchase.

Digoxin is used to treat heart failure and abnormal heart rhythms, according to the FDA. Tablets that contain a higher-than-labeled amount of the active ingredient may pose a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.